Annual Working Capital
$16.67 M
-$8.48 M-33.73%
December 31, 2023
Summary
- As of February 7, 2025, GRTX annual working capital is $16.67 million, with the most recent change of -$8.48 million (-33.73%) on December 31, 2023.
- During the last 3 years, GRTX annual working capital has fallen by -$47.29 million (-73.93%).
- GRTX annual working capital is now -84.55% below its all-time high of $107.88 million, reached on December 31, 2019.
Performance
GRTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$7.99 M
-$1.85 M-18.82%
September 1, 2024
Summary
- As of February 7, 2025, GRTX quarterly working capital is $7.99 million, with the most recent change of -$1.85 million (-18.82%) on September 1, 2024.
- Over the past year, GRTX quarterly working capital has dropped by -$8.69 million (-52.11%).
- GRTX quarterly working capital is now -92.89% below its all-time high of $112.37 million, reached on March 31, 2020.
Performance
GRTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
GRTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.7% | -52.1% |
| 3 y3 years | -73.9% | -52.1% |
| 5 y5 years | -78.5% | -52.1% |
GRTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -74.1% | at low | -87.6% | at low |
| 5 y | 5-year | -84.5% | at low | -92.9% | at low |
| alltime | all time | -84.5% | +53.4% | -92.9% | at low |
Galera Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.99 M(-18.8%) |
| Jun 2024 | - | $9.84 M(-25.3%) |
| Mar 2024 | - | $13.17 M(-21.0%) |
| Dec 2023 | $16.67 M(-33.7%) | $16.67 M(-10.4%) |
| Sep 2023 | - | $18.61 M(-34.4%) |
| Jun 2023 | - | $28.38 M(-30.7%) |
| Mar 2023 | - | $40.98 M(+62.9%) |
| Dec 2022 | $25.16 M(-61.0%) | $25.16 M(-24.4%) |
| Sep 2022 | - | $33.28 M(-24.7%) |
| Jun 2022 | - | $44.20 M(-18.7%) |
| Mar 2022 | - | $54.34 M(-15.7%) |
| Dec 2021 | $64.46 M | $64.46 M(-16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $76.96 M(-16.4%) |
| Jun 2021 | - | $92.02 M(+90.2%) |
| Mar 2021 | - | $48.38 M(-24.4%) |
| Dec 2020 | $63.96 M(-40.7%) | $63.96 M(-21.8%) |
| Sep 2020 | - | $81.80 M(-14.8%) |
| Jun 2020 | - | $96.00 M(-14.6%) |
| Mar 2020 | - | $112.37 M(+4.2%) |
| Dec 2019 | $107.88 M(+39.4%) | $107.88 M(+71.1%) |
| Sep 2019 | - | $63.06 M(-16.6%) |
| Jun 2019 | - | $75.60 M(-2.3%) |
| Dec 2018 | $77.41 M(+612.0%) | $77.41 M |
| Dec 2017 | $10.87 M | - |
FAQ
- What is Galera Therapeutics annual working capital?
- What is the all time high annual working capital for Galera Therapeutics?
- What is Galera Therapeutics annual working capital year-on-year change?
- What is Galera Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Galera Therapeutics?
- What is Galera Therapeutics quarterly working capital year-on-year change?
What is Galera Therapeutics annual working capital?
The current annual working capital of GRTX is $16.67 M
What is the all time high annual working capital for Galera Therapeutics?
Galera Therapeutics all-time high annual working capital is $107.88 M
What is Galera Therapeutics annual working capital year-on-year change?
Over the past year, GRTX annual working capital has changed by -$8.48 M (-33.73%)
What is Galera Therapeutics quarterly working capital?
The current quarterly working capital of GRTX is $7.99 M
What is the all time high quarterly working capital for Galera Therapeutics?
Galera Therapeutics all-time high quarterly working capital is $112.37 M
What is Galera Therapeutics quarterly working capital year-on-year change?
Over the past year, GRTX quarterly working capital has changed by -$8.69 M (-52.11%)